145.78999 USD
1.4096
0.96%
Last update Dec 16, 3:48 PM GMT
Main market
Day range
145.0099945
147.42000
Previous close
147.19960
Open
147.42000
Access this stock data via API
Subscribe
Axsome Therapeutics, Inc.
145.79
1.41
0.96%

Financials

Income statement

Fiscal date Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total reported revenue 9.3M 4.3M 4.3M 1.3M
Cost of revenue 7.5M 3.2M 3.2M 884K
Gross profit 1.8M 1.1M 1.1M 366K
Operating expense
Research & development 989K 944K 1.2M 787K
Selling general and admin 1.6M 1.4M 1.3M 1.1M
Other operating expenses -508K -226K -96K -30K
Operating income -366K -1.1M -1.4M -1.6M
Non operating interest income
Income
Expense 810K 622K 678K 590K
Other income expense 496K 253K -210K 7K
Pretax income -680K -1.5M -2.3M -2.2M
Tax provision
Net income -680K -1.5M -2.3M -2.2M
Basic EPS 0.0 0.0 0.0
Diluted EPS 0.0 0.0 0.0
Basic average shares 147.0M 146.6M 146.1M
Diluted average shares 147.0M 146.6M 146.1M
EBITDA -268K -992K -1.3M -1.5M
Net income from continuing op. -680K -1.5M -2.3M -2.2M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 4 hours 56 minutes

11:33
00:00
08:00
16:30
23:59

Trading Hours (Monday - Friday):

Pre-market
07:15 - 08:00
Main market
08:00 - 16:30
Post-market
16:30 - 17:15
All times are displayed in the Europe/London timezone (GMT, UTC+00:00).